Viewing Study NCT04551300


Ignite Creation Date: 2025-12-26 @ 12:14 PM
Ignite Modification Date: 2025-12-31 @ 9:37 PM
Study NCT ID: NCT04551300
Status: COMPLETED
Last Update Posted: 2022-10-18
First Post: 2020-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis Patients
Sponsor: Shanghai Alebund Pharmaceuticals Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module